How Big Biotech Can Win Back Investors


Big biotech stocks are trading at their lowest valuations in years, but don't underestimate their ability to turn things around quickly. The first-quarter earnings season, which starts next week, will highlight the struggles of the big players-weak growth and few new products.



from Biotech News